Please login to the form below

Not currently logged in
Email:
Password:

Activartis

This page shows the latest Activartis news and features for those working in and with pharma, biotech and healthcare.

FDA grants orphan status to Activartis’ brain cancer immunotherapy

FDA grants orphan status to Activartis’ brain cancer immunotherapy

FDA grants orphan status to Activartis’ brain cancer immunotherapy. Regulator says AV0113 has potential in rare cancer malignant glioma. ... Activartis' AV0113 is part of this growing trend, and the drug has shown promise in early-stage trials.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics